Performance of prognostic scores in predicting long-term outcome following resection of colorectal liver metastases

British Journal of Surgery

Volumn 101, Issue 7, 2014, Pages 856-866

  Roberts, K J ^b   White, A ^a   Cockbain, A ^a   Hodson, J ^c   Hidalgo, E ^a   Toogood, G J ^a   Lodge, J P A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b Hepatopancreatobiliary Unit   (United Kingdom)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LIVER TUMOR; LUNG TUMOR; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL RATE; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE;

AGED; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84900400187     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.9471     Document Type: Article

References (32)

1. Wagner JS, Adson MA, van Heerden JA, Adson MH, Ilstrup DM,. The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment. Ann Surg 1984; 199: 502-508.
2. Wood CB, Gillis CR, Blumgart LH,. A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2: 285-288.
3. Meyerhardt JA, Mayer RJ,. Systemic therapy for colorectal cancer. N Engl J Med 2005; 352: 476-487.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
5. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH,. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318.
6. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM,. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch Surg 1997; 132: 505-510.
7. Scheele J, Stang R, Altendorf-Hofmann A, Paul M,. Resection of colorectal liver metastases. World J Surg 1995; 19: 59-71.
8. Pulitanò C, Castillo F, Aldrighetti L, Bodingbauer M, Parks RW, Ferla G, et al. What defines 'cure' after liver resection for colorectal metastases? Results after 10 years of follow-up. HPB (Oxford) 2010; 12: 244-249.
9. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-4580.
10. Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L,. Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 2008; 15: 2458-2464.
11. Halazun KJ, Al Mukhtar A, Aldouri A, Malik HZ, Attia MS, Prasad KR, et al. Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg 2007; 246: 1065-1074.
12. Konopke R, Kersting S, Distler M, Dietrich J, Gastmeier J, Heller A, et al. Prognostic factors and evaluation of a clinical score for predicting survival after resection of colorectal liver metastases. Liver Int 2009; 29: 89-102.
13. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto T, et al. A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 2004; 11: 79-83.
14. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996; 77: 1254-1262.
15. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
16. Lodge JP, Ammori BJ, Prasad KR, Bellamy MC,. Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases. Ann Surg 2000; 231: 471-479.
17. Malde DJ, Khan A, Prasad KR, Toogood GJ, Lodge JP,. Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) 2011; 13: 802-810.
18. Iwatsuki S, Dvorchik I, Madariaga JR, Marsh JW, Dodson F, Bonham AC, et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189: 291-299.
19. Zakaria S, Donohue JH, Que FG, Farnell MB, Schleck CD, Ilstrup DM, et al., Hepatic resection for colorectal metastases: value for risk scoring systems? Ann Surg 2007; 246: 183-191.
20. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, Gomez D, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 2007; 246: 806-814.
21. Adair RA, Young AL, Cockbain AJ, Malde D, Prasad KR, Lodge JP, et al. Repeat hepatic resection for colorectal liver metastases. Br J Surg 2012; 99: 1278-1283.
22. Kulik U, Bektas H, Klempnauer J, Lehner F,. Repeat liver resection for colorectal metastases. Br J Surg 2013; 100: 926-932.
23. Jones RP, Jackson R, Dunne DF, Malik HZ, Fenwick SW, Poston GJ, et al. Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg 2012; 99: 477-486.
24. Narita M, Oussoultzoglou E, Jaeck D, Fuchschuber P, Rosso E, Pessaux P, et al. Two-stage hepatectomy for multiple bilobar colorectal liver metastases. Br J Surg 2011; 98: 1463-1475.
25. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, et al. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 2013; 100: 1777-1783.
26. Stremitzer S, Stift J, Gruenberger B, Tamandl D, Aschacher T, Wolf B, et al. KRAS status and outcome of liver resection after neoadjuvant chemotherapy including bevacizumab. Br J Surg 2012; 99: 1575-1582.
27. Ayez N, Lalmahomed ZS, van der Pool AE, Vergouwe Y, van MK, de Jonge J, et al. Is the clinical risk score for patients with colorectal liver metastases still useable in the era of effective neoadjuvant chemotherapy? Ann Surg Oncol 2011; 18: 2757-2763.
28. Ueno H, Mochizuki H, Hatsuse K, Hase K, Yamamoto T,. Indicators for treatment strategies of colorectal liver metastases. Ann Surg 2000; 231: 59-66.
29. Schindl M, Wigmore SJ, Currie EJ, Laengle F, Garden OJ,. Prognostic scoring in colorectal cancer liver metastases: development and validation. Arch Surg 2005; 140: 183-189.
30. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati P,. Patterns of recurrence after resection of colorectal liver metastases: prediction by models of outcome analysis. World J Surg 2001; 25: 638-644.
31. Andres A, Toso C, Adam R, Barroso E, Hubert C, Capussotti L, et al. A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg 2012; 256: 772-778.
32. Hosmer DW, Lemeshow S,. Applied Logistic Regression (2nd edn). John Wiley & Sons: New York, 2000.